News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Medtronic slipped to about $102 after its MiniMed separation, viewed as a buyable pullback.
  • Analysts cite Medtronic's ~$6.1B free cash flow and 2.8% yield to justify a long trade with $125 target.
  • IREN has fallen roughly 70% from highs yet maintains a $20.3B contract backlog and rising AI cloud revenue.
  • IREN is highly levered and cash-burning, making any upside contingent on execution and financing.
  • Healthcare and AI stocks are being pitched as opportunistic longs ahead of near-term catalysts.
  • Overall market tone from these pitches favors selective, execution-dependent risk-taking.

Latest Articles

Bank Rate to Stay at 3.75% as Inflation Risks from Middle East Persist

Bank Rate to Stay at 3.75% as Inflation Risks from Middle East Persist

A July 21-24 poll of 70 economists finds unanimous expectation that the Bank of England will keep its policy rate at 3.75% on Thursday and likely maintain it through much of 2026 as inflation remains above target. A temporary dip in June inflation to 2.6% followed a brief easing of conflict in the Gulf and lower fuel prices, but renewed hostilities…

Chris Brown Enters Guilty Plea for Affray in London Nightclub Incident

Chris Brown Enters Guilty Plea for Affray in London Nightclub Incident

U.S. singer Chris Brown and co-defendant Omololu Akinlolu pleaded guilty to affray over a February 2023 incident at Tape nightclub in London. Prosecutors said they will not pursue separate charges alleging attempted grievous bodily harm or assault causing actual bodily harm. Sentencing is set for October 26 at Southwark Crown Court.

Rani Therapeutics Director Mir A Imran Acquires $24,839 in Stock Amid Clinical and Corporate Developments

Rani Therapeutics Director Mir A Imran Acquires $24,839 in Stock Amid Clinical and Corporate Developments

Mir A. Imran, a director and significant shareholder in Rani Therapeutics Holdings, Inc. (NASDAQ:RANI), recently executed a purchase of 36,000 shares of the company's Class A Common Stock. This transaction, valued at $24,839, occurred against a backdrop of recent corporate developments, including the announcement of positive initial data from a Pha…

BiomX Subsidiary Zorronet Expands European Presence Through Two Strategic Collaborations in Europe

BiomX Subsidiary Zorronet Expands European Presence Through Two Strategic Collaborations in Europe

BiomX Inc., through its subsidiary Zorronet Ltd., has entered into two strategic collaborations with Samura s.r.o. to deploy AI-powered monitoring solutions in Central and Eastern Europe. These collaborations target smart pest management in agriculture and the protection of critical transportation infrastructure, leveraging AI to improve efficiency…

Buy the Pullback in AppLovin - Growth Intact, Market Flinching

Buy the Pullback in AppLovin - Growth Intact, Market Flinching

AppLovin (APP) pulled back on sentiment and headline risk, but fundamentals remain strong: Q1 2026 revenue near $1.8B (roughly 59% YoY), EPS near $11.80, and management is repurchasing stock. Valuation is rich but supported by high returns and fast top-line growth. This trade idea is a disciplined long with clear entry, stop and target, sized to a …

Cytokinetics EVP Fady Malik Sells Stock Amid Myqorzo Launch Momentum

Cytokinetics EVP Fady Malik Sells Stock Amid Myqorzo Launch Momentum

Cytokinetics Inc. (NASDAQ: CYTK) Executive Vice President of Research & Development Fady Malik executed a series of transactions on July 21, 2026, selling 3,500 shares of common stock while simultaneously exercising non-qualified stock options to acquire an equal number of shares. The sale was reported at $80.59 per share, totaling $282,065, while …

Acrivon Therapeutics CLO Mary Miller Sells $1,008 in Company Stock

Acrivon Therapeutics CLO Mary Miller Sells $1,008 in Company Stock

Mary Miller, Chief Legal Officer at Acrivon Therapeutics, Inc. (NASDAQ:ACRV), executed a $1,008 sale of the company's common stock on July 21, 2026. The transaction involved the automatic disposition of 573 shares at $1.76 each to satisfy mandatory tax withholding requirements triggered by the vesting of restricted stock units. Following the transa…

CN Declares Third-Quarter 2026 Dividend

CN Declares Third-Quarter 2026 Dividend

Canadian National Railway (CN) announced its Board of Directors has approved a quarterly dividend of C$0.9150 per common share, payable on September 29, 2026, to shareholders of record as of September 8, 2026. CN continues to power the economy by safely transporting over 300 million tons of goods annually across its extensive North American rail ne…

Dyadic Announces Continued Listing on the Nasdaq Capital Market

Dyadic Announces Continued Listing on the Nasdaq Capital Market

Dyadic International, Inc., a biotechnology company specializing in recombinant protein production platforms, announced that it has regained compliance with Nasdaq listing requirements, ensuring its common stock continues to be listed on the Nasdaq Capital Market. The company plans to focus on executing its business strategy, including the commerci…

Zevra Therapeutics Provides Update on Regulatory Submission for Arimoclomol for the Treatment of Niemann-Pick Disease Type C (NPC) in the European Union

Zevra Therapeutics Provides Update on Regulatory Submission for Arimoclomol for the Treatment of Niemann-Pick Disease Type C (NPC) in the European Union

Zevra Therapeutics announced the Committee for Medicinal Products for Human Use (CHMP) issued a negative opinion on the Marketing Authorization Application (MAA) for arimoclomol to treat Niemann-Pick disease type C in the European Union. The company plans to request a re-examination of the decision while continuing to provide access to the drug thr…

Alphabet Selloff Over AI Capex Looks Overdone - A Defined Long Trade

Alphabet Selloff Over AI Capex Looks Overdone - A Defined Long Trade

Alphabet plunged after management signaled dramatically higher AI infrastructure spending. The market is punishing the company for higher near-term capex, but core ad growth, record YouTube ad revenue and a fortress-like free cash flow profile keep the long-term thesis intact. This trade idea lays out a precise entry at the current price, an asymme…

TSMC: Great Numbers, Aggressive Market - Time to Pick a Side

TSMC: Great Numbers, Aggressive Market - Time to Pick a Side

Taiwan Semiconductor (TSM) reported robust Q2 growth and raised guidance, but the stock is priced richly and showing signs of short-term technical fatigue. We lay out a mid-term (45 trading days) short trade: enter at $415.49, stop at $445.00, target $350.00. Trade rationale, catalysts, and four-plus risks explained.

Verizon Raises Full-Year Guidance After Strong Wireless Subscriber Growth

Verizon Raises Full-Year Guidance After Strong Wireless Subscriber Growth

Verizon lifted its annual adjusted earnings and free cash flow outlook after adding more monthly-bill wireless subscribers than analysts expected in the second quarter. The gains followed the rollout of simplified unlimited 5G plans, a loyalty program and a bundled wireless-home internet product, even as second-quarter revenue missed estimates beca…

WFP Signals Risk of Deeper Aid Reductions in Gaza as Funding Dries Up

WFP Signals Risk of Deeper Aid Reductions in Gaza as Funding Dries Up

The U.N. World Food Programme has warned it will need to scale back aid in Gaza unless fresh funding is secured. The agency, which supplies food to roughly 70% of Gaza’s residents, said shortfalls and rising operational costs are already forcing cutbacks and that the number of people facing acute hunger is projected to rise by December if assistanc…

Radiopharm Theranostics Announces Concurrent US$4.1 Million Registered Direct Offering and Up To Additional A$12.7 (US$8.9) Million Australian Placement and Share Purchase Plan

Radiopharm Theranostics Announces Concurrent US$4.1 Million Registered Direct Offering and Up To Additional A$12.7 (US$8.9) Million Australian Placement and Share Purchase Plan

Radiopharm Theranostics Limited announces a concurrent securities offering including a $4.1 million registered direct offering of ADSs in the US, an AUD 6.7 million Australian private placement (subject to shareholder approval), and a share purchase plan to raise an additional AUD 6 million. The company plans to use the proceeds to support the comm…

Warsh’s Quiet Fed Meets a Loud Bond Market as Long-Term Yields Surge

Warsh’s Quiet Fed Meets a Loud Bond Market as Long-Term Yields Surge

A sharp repricing in U.S. Treasury markets has driven two-, 10- and 30-year yields to their highest levels in years. Market reactions to rising oil prices, geopolitical uncertainty around Iran, and solid U.S. economic data are combining with Federal Reserve Chairman Kevin Warsh's decision to reduce forward guidance, producing rapid shifts in expect…

Salesforce Shares Rise After $1.6 Billion VA Contract via Missionforce

Salesforce Shares Rise After $1.6 Billion VA Contract via Missionforce

Salesforce shares climbed in pre-market trading following disclosure of a $1.6 billion agreement with the U.S. Department of Veterans Affairs through the company’s Missionforce government unit. The one-year Agentic Enterprise License Agreement includes options for two one-year renewals and bolsters a string of large federal awards that support Sale…

Salesforce Wins $1.6 Billion VA Contract, Shares Tick Higher

Salesforce Wins $1.6 Billion VA Contract, Shares Tick Higher

Salesforce shares rose after the company secured a $1.6 billion, three-year Agentic Enterprise License Agreement from the U.S. Department of Veterans Affairs. The deal will use Salesforce’s Missionforce platform, AI-powered agents, Slack collaboration, and analytics tools to modernize care delivery and scheduling across the VA network.